SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-22-021277
Filing Date
2022-11-02
Accepted
2022-11-02 16:31:27
Documents
52
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 6-K asnd-20220930.htm   iXBRL 6-K 2465957
2 GRAPHIC img146716393_0.jpg GRAPHIC 44322
3 GRAPHIC img146716393_1.jpg GRAPHIC 82999
4 GRAPHIC img146716393_2.jpg GRAPHIC 44326
  Complete submission text file 0000950170-22-021277.txt   8226895

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asnd-20220930_lab.xml EX-101.LAB 348741
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asnd-20220930_cal.xml EX-101.CAL 48976
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asnd-20220930.xsd EX-101.SCH 46811
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asnd-20220930_def.xml EX-101.DEF 173666
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asnd-20220930_pre.xml EX-101.PRE 263033
46 EXTRACTED XBRL INSTANCE DOCUMENT asnd-20220930_htm.xml XML 1639180
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 221354621
SIC: 2834 Pharmaceutical Preparations